In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
Furthermore, current immunomodulatory therapies, including immunosuppressants and biologics, remain predominantly palliative
Additionally, GSH shifts the melanogenesis pathway away from eumelanin (the darker brown/black pigment) toward pheomelanin (the lighter red/orange pigment) by interacting with dopaquinone intermediates in the Raper-Mason pathway
Patience is part of the deal
After birth, the lambs exhibited metabolic acidosis, a blood disorder involving changes such as decreased blood pH, lower total carbon dioxide, bicarbonate, and ionized calcium levels, and base excess, as well as increased lactate concentrations (Yilmaz et al., 2024)